Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis

MLA

Kavita Radhakrishnan, et al. “Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis.” Hepatology Communications, vol. 3, no. 10, Oct. 2019, pp. 1388–99. EBSCOhost, https://doi.org/10.1002/hep4.1412.

APA

Kavita Radhakrishnan, Adrian M. Di Bisceglie, K. Rajender Reddy, Joseph K. Lim, Josh Levitsky, Mohamed A. Hassan, Jama M. Darling, Jordan J. Feld, Lucy Akushevich, Monika Vainorius, David R. Nelson, Michael W. Fried, Robert S. Brown Jr., & Norah A. Terrault. (2019). Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis. Hepatology Communications, 3(10), 1388–1399. https://doi.org/10.1002/hep4.1412

Chicago

Kavita Radhakrishnan, Adrian M. Di Bisceglie, K. Rajender Reddy, Joseph K. Lim, Josh Levitsky, Mohamed A. Hassan, Jama M. Darling, et al. 2019. “Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis.” Hepatology Communications 3 (10): 1388–99. doi:10.1002/hep4.1412.